Trader consensus prices "Yes" at 75% implied probability for a CDC Level 3 Travel Health Notice by December 31, 2026, driven by ongoing Level 2 alerts for escalating outbreaks including meningococcal disease in the Democratic Republic of the Congo (updated March 24), yellow fever in Venezuela, and chikungunya across Mayotte, Suriname, Bolivia, and Seychelles, alongside global poliovirus circulation in over 20 countries. These reflect confirmed case surges from CDC surveillance, heightening risks of further intensification warranting "Reconsider Nonessential Travel" elevation, as seen historically with pathogens like mpox clade II in Ghana and Liberia. Persistent H5N1 avian influenza detections—71 U.S. human cases since 2024, recent cat infections in 18 states, and Cambodia's 2026 cases—add epidemiological pressure without person-to-person transmission yet. Weekly FluView reports and WHO updates through year-end will clarify trajectories amid inherent forecasting uncertainties.
สรุปจาก AI ทดลองที่อ้างอิงข้อมูลจาก Polymarket ไม่ใช่คำแนะนำในการเทรดและไม่มีผลต่อการตัดสินตลาดนี้ · อัปเดตแล้วCDC issues Level 3 warning by December 31?
CDC issues Level 3 warning by December 31?
$112,110 ปริมาณ
$112,110 ปริมาณ
Dec 31, 2026
$112,110 ปริมาณ
$112,110 ปริมาณ
Dec 31, 2026
This market will resolve to "Yes" if the CDC issues a Level 3 (“Reconsider Nonessential Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 3 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.Trader consensus prices "Yes" at 75% implied probability for a CDC Level 3 Travel Health Notice by December 31, 2026, driven by ongoing Level 2 alerts for escalating outbreaks including meningococcal disease in the Democratic Republic of the Congo (updated March 24), yellow fever in Venezuela, and chikungunya across Mayotte, Suriname, Bolivia, and Seychelles, alongside global poliovirus circulation in over 20 countries. These reflect confirmed case surges from CDC surveillance, heightening risks of further intensification warranting "Reconsider Nonessential Travel" elevation, as seen historically with pathogens like mpox clade II in Ghana and Liberia. Persistent H5N1 avian influenza detections—71 U.S. human cases since 2024, recent cat infections in 18 states, and Cambodia's 2026 cases—add epidemiological pressure without person-to-person transmission yet. Weekly FluView reports and WHO updates through year-end will clarify trajectories amid inherent forecasting uncertainties.
This market will resolve to "Yes" if the CDC issues a Level 3 (“Reconsider Nonessential Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 3 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
A Level 3 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
ตลาดเปิดเมื่อ: Jan 19, 2026, 3:15 PM ET
ปริมาณการซื้อขาย
$112,110วันสิ้นสุด
Dec 31, 2026ตลาดเปิดเมื่อ
Jan 19, 2026, 3:15 PM ETResolver
0x65070BE91...This market will resolve to "Yes" if the CDC issues a Level 3 (“Reconsider Nonessential Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 3 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.Trader consensus prices "Yes" at 75% implied probability for a CDC Level 3 Travel Health Notice by December 31, 2026, driven by ongoing Level 2 alerts for escalating outbreaks including meningococcal disease in the Democratic Republic of the Congo (updated March 24), yellow fever in Venezuela, and chikungunya across Mayotte, Suriname, Bolivia, and Seychelles, alongside global poliovirus circulation in over 20 countries. These reflect confirmed case surges from CDC surveillance, heightening risks of further intensification warranting "Reconsider Nonessential Travel" elevation, as seen historically with pathogens like mpox clade II in Ghana and Liberia. Persistent H5N1 avian influenza detections—71 U.S. human cases since 2024, recent cat infections in 18 states, and Cambodia's 2026 cases—add epidemiological pressure without person-to-person transmission yet. Weekly FluView reports and WHO updates through year-end will clarify trajectories amid inherent forecasting uncertainties.
This market will resolve to "Yes" if the CDC issues a Level 3 (“Reconsider Nonessential Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 3 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
A Level 3 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
ปริมาณการซื้อขาย
$112,110วันสิ้นสุด
Dec 31, 2026ตลาดเปิดเมื่อ
Jan 19, 2026, 3:15 PM ETResolver
0x65070BE91...Trader consensus prices "Yes" at 75% implied probability for a CDC Level 3 Travel Health Notice by December 31, 2026, driven by ongoing Level 2 alerts for escalating outbreaks including meningococcal disease in the Democratic Republic of the Congo (updated March 24), yellow fever in Venezuela, and chikungunya across Mayotte, Suriname, Bolivia, and Seychelles, alongside global poliovirus circulation in over 20 countries. These reflect confirmed case surges from CDC surveillance, heightening risks of further intensification warranting "Reconsider Nonessential Travel" elevation, as seen historically with pathogens like mpox clade II in Ghana and Liberia. Persistent H5N1 avian influenza detections—71 U.S. human cases since 2024, recent cat infections in 18 states, and Cambodia's 2026 cases—add epidemiological pressure without person-to-person transmission yet. Weekly FluView reports and WHO updates through year-end will clarify trajectories amid inherent forecasting uncertainties.
สรุปจาก AI ทดลองที่อ้างอิงข้อมูลจาก Polymarket ไม่ใช่คำแนะนำในการเทรดและไม่มีผลต่อการตัดสินตลาดนี้ · อัปเดตแล้ว
ระวังลิงก์ภายนอก
ระวังลิงก์ภายนอก
คำถามที่พบบ่อย